Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Sees Significant Decline in Short Interest

Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) was the recipient of a large drop in short interest in October. As of October 31st, there was short interest totalling 800 shares, a drop of 98.0% from the October 15th total of 39,700 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Quantum Genomics Société Anonyme Price Performance

Shares of OTCMKTS QNNTF remained flat at $0.10 during trading on Thursday. Quantum Genomics Société Anonyme has a 52-week low of $0.10 and a 52-week high of $0.10. The business has a fifty day moving average of $0.10 and a 200 day moving average of $0.10.

Quantum Genomics Société Anonyme Company Profile

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure.